Cambridge Enterprise has put cash into CardiaTec Biosciences in a pre-seed round that marks the inaugural deal for Laidlaw Scholars Ventures.

Oxford Quantum Circuits' series A round is already among the largest for a European quantum company and could still go higher.

UT Southwestern Medical Center spinout ReCode Therapeutics has now raised a total of $200m in its series B round from investors including Osage University Partners.

University of Washington spinout Zap Energy is working on building a cheap, scalable fusion reactor generating low cost and carbon free energy.

Osage University Partners has added MicroTransponder to a small but mightly portfolio of medical device companies.

Chalmers spinout Elypta is working on a metabolism-based liquid biopsy for early cancer detection that it hopes will catch any type of the disease.

Orphan CNS therapy developer Minoryx Therapeutics closed a $54.8m series C and MIT's The Engine co-led a $10.5m seed round for Foundation Alloy.

Evotec has bought University of Modena and Reggio Emilia spinout Rigenerand for $24.7m.